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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to “slowly 
digestible starch in starch-containing foods” and “reduction of post-
prandial glycaemic responses” pursuant to Article 13(5) of Regulation (EC) 
No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Kraft Foods Europe, submitted pursuant to Article 13(5) of Regulation (EC) No 
1924/2006 via the Competent Authority of Belgium, the EFSA Panel on Dietetic Products, Nutrition and 
Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to “slowly 
digestible starch in starch-containing foods” and “reduction of post-prandial glycaemic responses”. The food 
constituent, “slowly digestible starch (SDS)”, as defined by the applicant in applying an appropriate method 
(such as the method developed by Englyst et al. (1996; 1999)), which is the subject of the health claim, and the 
comparator food constituent, “rapidly digestible starch (RDS)”, as defined by the applicant, are sufficiently 
characterised in relation to the claimed effect. The claimed effect, reduction of post-prandial glycaemic responses 
(as long as post-prandial insulinaemic responses are not disproportionally increased), may be a beneficial 
physiological effect. The studies provided consistently showed that consumption of 40-50 % of digestible starch 
as “SDS” in cereal products containing about 55-70 % of available carbohydrates as starch and 30-45 % as 
sugars in the context of a meal providing at least 60 E% of available carbohydrates induced significantly lower 
post-prandial glycaemic responses (without leading to disproportionally increased post-prandial insulinaemic 
responses) than the consumption of all digestible starch as “RDS” in cereal products with a similar content of 
available carbohydrates, starch and sugars. Cereal products, however, providing around 30 % of digestible starch 
as “SDS” and containing around 70 % of available carbohydrates as starch and 30 % as sugars did not show such 
an effect. A cause and effect relationship has been established between the consumption of “SDS”, as compared 
to the consumption of “RDS”, in cereal products and reduced post-prandial glycaemic responses (without 
disproportionally increased post-prandial insulinaemic responses). © European Food Safety Authority, 2011 
                                                     
1  On request from the Competent Authority of Belgium following an application by Kraft Foods Europe, Question No 
EFSA-Q-2010-00966, adopted on 30 June 2011. 
2  Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, 
Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, 
Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, 
Hendrik van Loveren and Hans Verhagen. One member of the Panel did not participate in the discussion on the subject 
referred to above because of potential conflicts of interest identified in accordance with the EFSA policy on declarations of 
interests. Correspondence: nda@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Claims for the preparatory work on 
this scientific opinion: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina 
Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, 
Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. 
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SUMMARY 
Following an application from Kraft Foods Europe, submitted pursuant to Article 13(5) of Regulation 
(EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, 
Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health 
claim related to “slowly digestible starch in starch-containing foods” and “reduction of post-prandial 
glycaemic responses”. 
The scope of the application was proposed to fall under a health claim referring to a health claim 
based on newly developed scientific evidence and/or a health claim including a request for the 
protection of proprietary data. 
The food constituent that is the subject of the health claim is “slowly digestible starch (SDS)” as 
compared to “rapidly digestible starch (RDS)” in starch-containing foods. The Panel considers that 
the food constituent, “SDS”, as defined by the applicant in applying an appropriate method (such as 
the method developed by Englyst et al. (1996; 1999)), which is the subject of the health claim, and the 
comparator food constituent, “RDS”, as defined by the applicant, are sufficiently characterised in 
relation to the claimed effect.  
The claimed effect proposed by the applicant relates to the reduction of post-prandial glycaemic 
responses. The target population proposed for the claim is the general population. The Panel considers 
that reduction of post-prandial glycaemic responses (as long as post-prandial insulinaemic responses 
are not disproportionally increased) may be a beneficial physiological effect.  
The applicant provided five human intervention studies (four claimed as proprietary by the applicant) 
for the scientific substantiation of the claim. In these studies, the effect of consuming cereal products 
high in “SDS” compared to consuming cereal products low in “SDS” and high in “RDS” on post-
prandial blood glucose and insulin responses was investigated.  
The Panel notes that the studies provided consistently showed that consumption of 40-50 % of 
digestible starch as “SDS” in cereal products containing about 55-70 % of available carbohydrates as 
starch and 30-45 % as sugars in the context of a meal providing at least 60 E% of available 
carbohydrates induced significantly lower post-prandial glycaemic responses (without leading to 
disproportionally increased post-prandial insulinaemic responses) than the consumption of all 
digestible starch as “RDS” in cereal products with a similar content of available carbohydrates, starch 
and sugars. Cereal products, however, providing around 30 % of digestible starch as “SDS” and 
containing around 70 % of available carbohydrates as starch and 30 % as sugars did not show such an 
effect. The Panel also notes that a reduction in the sugar content in these cereal products is expected 
to have a similar effect on post-prandial glycaemic responses. 
The Panel concludes that a cause and effect relationship has been established between the 
consumption of “SDS”, as compared to the consumption of “RDS”, in cereal products and reduced 
post-prandial glycaemic responses (without disproportionally increased post-prandial insulinaemic 
responses). 
The Panel could have reached the conclusion that the rate of starch digestibility assessed in vitro in 
cereal products has an effect on post-prandial glycaemic responses in vivo in humans without the data 
marked as proprietary by the applicant. However, the four unpublished studies claimed as proprietary 
by the applicant were required to establish conditions of use for this specific claim.  
The Panel considers that the following wording reflects the scientific evidence: “Consumption of 
cereal products high in slowly digestible starch raises blood glucose concentrations less after a meal 
than cereal products low in slowly digestible starch”. 
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The Panel considers that, in order to bear the claim, cereal products should contain at least 55 % of 
available carbohydrates as starch of which at least 40 % should be “SDS”. The target population is 
individuals who wish to reduce their post-prandial blood glucose responses.  
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BACKGROUND 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health), which are based on newly developed 
scientific evidence or include a request for the protection of proprietary data, to the Community list of 
permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for authorisation or inclusion in the 
Community list of permitted claims referred to in Article 13(3) shall be submitted by the applicant to 
the national competent authority of a Member State, which will make the application and any 
supplementary information supplied by the applicant available to the European Food Safety Authority 
(EFSA). 
STEPS TAKEN BY EFSA: 
 The application was received on 08/07/2010. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence and/or including a request for the protection of proprietary data. 
 During the check for completeness5 of the application, the applicant was requested to provide 
clarifications/additional information on 30/07/2010. 
 The applicant provided the clarifications/additional information on 18/10/2010. 
 The scientific evaluation procedure started on 30/10/2010. 
 On 25/02/2011, the NDA Panel Working Group on Claims agreed on a list of questions for 
the applicant to provide additional information to accompany the application and on 
01/03/2011, EFSA requested the applicant to provide this additional information. The clock 
was stopped from 04/03/2011 to 18/03/2011. 
 The applicant submitted the responses to EFSA’s request on 18/03/2011. 
 On 06/04/2011, the NDA Panel agreed on a list of questions for the applicant to provide 
additional information to accompany the application and on 07/04/2011, EFSA requested the 
applicant to provide this additional information. The clock was stopped from 11/04/2011 to 
26/04/2011. 
 The applicant submitted the responses to EFSA’s request on 26/04/2011. 
 On 13/05/2011, the NDA Panel agreed on a list of questions for the applicant to provide 
additional information to accompany the application and on 16/05/2011, EFSA requested the 
applicant to provide this additional information. The clock was stopped from 17/05/2011 to 
30/05/2011. 
 The applicant submitted the responses to EFSA’s request on 30/05/2011. 
                                                     
4  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25.  
5  In accordance with: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011. Scientific and technical 
guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1). EFSA 
Journal, 9(5):2170, 36 pp. 
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 On 30/06/2011, the NDA Panel, after having evaluated the overall data submitted, adopted an 
opinion on the scientific substantiation of a health claim related to “slowly digestible starch in 
starch-containing foods” and “reduction of post-prandial glycaemic responses”. 
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to “slowly digestible starch in starch-
containing foods” and “reduction of post-prandial glycaemic responses”. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation to the marketing 
of “slowly digestible starch in starch-containing foods”, a positive assessment of its safety, nor a 
decision on whether “slowly digestible starch in starch-containing foods” is, or is not, classified as a 
foodstuff. It should be noted that such an assessment is not foreseen in the framework of Regulation 
(EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wording of the claim and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
“Slowly digestible starch in starch-containing foods” and  
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Kraft Foods Europe - Biscuits R&D, 6 Rue Razel, 91400 Saclay - 
France.  
The application includes a request for the protection of proprietary data in accordance with Article 21 
of Regulation (EC) No 1924/2006. 
Food/constituent as stated by the applicant 
According to the applicant the food, which is the subject of the health claim, is “biscuits for 
breakfast”. After clarification sought by EFSA, the applicant indicated that the food, which is the 
subject of the claim, is slowly digestible starch in starch-containing foods. 
Health relationship as claimed by the applicant 
According to the applicant the health relationship relates to the appearance, in the blood circulation, 
of exogenous glucose from biscuits consumed for breakfast that is moderate and stable throughout the 
morning. After clarification sought by EFSA, the applicant indicated that the health relationship 
relates to the reduction of post-prandial glycaemic responses induced by the consumption of slowly 
digestible starch (SDS) when consumed in replacement of rapidly digestible (RDS) starch in starch-
containing foods. 
Wording of the health claim as proposed by the applicant 
The applicant proposes the following wording: Slowly digestible starch provides carbohydrates that 
are regularly and continuously absorbed and released. They contribute to a moderate post-prandial 
glycaemic response. 
Specific conditions of use as proposed by the applicant 
The applicant proposes the following conditions: A minimum of 31 % of SDS/RDS+SDS and at least 
20 g of the total amount of RDS and SDS per meal. 
ASSESSMENT 
1. Characterisation of the food/constituent 
The food constituent that is the subject of the health claim is “slowly digestible starch (SDS)” as 
compared to “rapidly digestible starch (RDS)” in starch-containing foods.  
SDS is defined by the applicant in this particular case by the rate and extent of starch digestion in 
starch-containing foods estimated by an in vitro method developed by Englyst et al. (1996; 1999). 
Briefly, food samples are analysed for free-sugar glucose (FSG) and fructose following in vivo 
chewing or mechanical mincing/crushing. Then, food samples are incubated with pancreatic enzymes 
(invertase, amylase, amyloglucosidase), and the amount of free glucose is measured at 20 (G20) and 
120 (G120) minutes. Food samples are further incubated and treated to obtain the total glucose portion. 
The amount of RDS is calculated as the difference between G20 and FSG multiplied by a factor of 0.9, 
and the amount of SDS by the difference between G120 and G20 multiplied by a factor of 0.9. Resistant 
starch (RS) is calculated as the difference between total glucose and G120 multiplied by a factor of 0.9. 
The Panel notes that this application refers to the digestible fraction of starch.  
“Slowly digestible starch in starch-containing foods” and  
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The Panel considers that the food constituent, “SDS”, as defined by the applicant in applying an 
appropriate method (such as the method developed by Englyst et al. (1996; 1999)), which is the 
subject of the health claim, and the comparator food constituent, “RDS”, as defined by the applicant, 
are sufficiently characterised in relation to the claimed effect.  
2. Relevance of the claimed effect to human health 
The claimed effect proposed by the applicant relates to the reduction of post-prandial glycaemic 
responses. The target population proposed for the claim is the general population. 
Postprandial glycaemia is interpreted as the elevation of blood glucose concentrations after 
consumption of a food and/or meal. This function is a normal physiological response which varies in 
magnitude and duration, and which may be influenced by the chemical and physical nature of the food 
or meal consumed, as well as by individual factors (Venn and Green, 2007). Decreasing post-prandial 
glycaemic responses may, for example, be beneficial to individuals with impaired glucose tolerance, 
as long as post-prandial insulinaemic responses are not disproportionally increased. Impaired glucose 
tolerance is common in the general population of adults.  
The Panel considers that reduction of post-prandial glycaemic responses (as long as post-prandial 
insulinaemic responses are not disproportionally increased) may be a beneficial physiological effect.  
3.  Scientific substantiation of the claimed effect 
The applicant provided four unpublished human intervention studies (identified as proprietary data) 
and one published human intervention study, all of which compared the effect of consuming cereal 
products high in “SDS” to consuming cereal products low in “SDS” and high in “RDS” on post-
prandial blood glucose concentrations in healthy subjects. 
In an open-label, randomised, controlled cross-over study (Rabasa-Lhoret et al., 2007, unpublished) 
the effect of three different breakfast biscuits and one extruded wheat flake cereal product (control) 
consumed with breakfast on post-prandial blood glucose and insulin responses was investigated in 
19 healthy females (19-26 years) after an overnight fast. The intervention breakfasts consisted of 
71.8 g breakfast biscuits and 150 mL skimmed milk. The control breakfast was composed of 66 g 
extruded wheat flakes, 150 mL skimmed milk and 4.5 g of a 50/50 rapeseed oil/palm olein oil 
mixture. Subjects were allowed to consume a maximum of 300 mL decaffeinated/detheinated 
unsweetened coffee or tea with the breakfasts. The four breakfasts, which provided around 380 kcal 
of energy, were comparable with respect to macronutrient composition and dietary fibre content. The 
cereal products tested were comparable for total digestible starch (biscuits: 33-37 g, wheat flakes: 
34.1 g), total sugars (biscuits: 14.6-18.5 g, wheat flakes: 17.4 g) and total fructose (biscuits: 7.1-9.9 g, 
wheat flakes: 8.9 g). The biscuits contained 41.9-46.4 % of total digestible starch as “SDS” while this 
value for the control breakfast was 0.3 %. Breakfasts were consumed on four occasions separated by a 
28±3 day wash-out period. Blood glucose and insulin concentrations were measured at baseline, every 
15 min up to 90 min and thereafter every 30 min up to 270 min. Four subjects dropped out during the 
study. Data from one of the four subjects, who did not complete the study but attended all but one 
visit, were taken into account in the analysis. The incremental area under the curve (iAUC) for blood 
glucose concentrations (T0-T120 min) was significantly lower after the consumption of the 
intervention breakfasts than after the control breakfast (mean±SEM 153.9±14.7, 137.1±12.3, 
150.7±16.4 vs. 224.2±22.0 mmol/L/min; p=0.003, p<0.001, p=0.002) as was the iAUC for insulin 
(T0-T120 min; mean±SEM 2166±227, 2224±196, 2301±226 vs. 3351±296 IU/L/min; p=0.002 for all 
comparisons). The Panel notes that the consumption of 40 % of digestible starch as “SDS” induced 
significantly lower post-prandial glycaemic responses (without leading to disproportionally increased 
post-prandial insulinaemic responses) than the consumption of all digestible starch as “RDS” in cereal 
products containing about 67 % of available carbohydrates as starch and 33 % as sugars.  
“Slowly digestible starch in starch-containing foods” and  
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In an open-label, randomised, controlled cross-over study (Brand-Miller et al., 2006, unpublished) the 
effect of breakfast biscuits and an extruded wheat flake product consumed with breakfast on post-
prandial blood glucose and insulin responses after an overnight fast was investigated in 13 healthy 
adult men (21.3-26.4 years). The two breakfasts were consumed on two separate occasions separated 
by a wash-out period of at least one day. The intervention breakfast consisted of 70 g breakfast 
biscuits and 250 mL semi-skimmed milk. The control breakfast was composed of 70 g extruded wheat 
flakes and 250 mL of full fat milk. Subjects were allowed to consume a maximum of 300 mL 
unsweetened coffee or tea with the breakfasts. The breakfasts, which provided around 450 kcal of 
energy, were comparable with respect to macronutrient composition and dietary fibre content. The 
cereal products tested were comparable for total digestible starch (biscuits: 37.1 g, wheat flakes: 
41.3 g), total sugars (biscuits: 15.4 g, wheat flakes: 16.5 g) and total fructose (biscuits: 7.5 g, wheat 
flakes: 8.0 g). The biscuits contained 39.9 % of total digestible starch as “SDS”, while this value for 
the control breakfast was 1.5 %. Blood glucose and insulin concentrations were measured at baseline, 
at 15 min, at 20 min, every 10 min up to 60 min, every 15 min up to 120 min, every 30 min up to 
180 min, every 15 min up to 240 min and at 270 min. All subjects completed the study. The iAUC for 
blood glucose concentrations (T0-T120 min) was significantly lower after the consumption of the 
intervention breakfast than after the control breakfast (mean±SEM 100.6±11.3 vs. 
142.7±11.3 mmol/L/min; p=0.01) as was the iAUC for insulin (T0-T120 min; mean±SEM 3528±358 
vs. 2517±358 IU/L/min; p<0.01). The Panel notes that the consumption of 40 % of digestible starch as 
“SDS” induced significantly lower post-prandial glycaemic responses (without leading to 
disproportionally increased post-prandial insulinaemic responses) than the consumption of all 
digestible starch as “RDS” in cereal products containing about 70 % of available carbohydrates as 
starch and 30 % as sugars.  
In an open-label, randomised, controlled cross-over study (Vinoy et al., 2000, unpublished) the effect 
of breakfast biscuits and chocolate flavoured cereals consumed with breakfast on post-prandial blood 
glucose and insulin responses after an overnight fast was investigated in 12 healthy subjects (6 
females, 18-40 years). Breakfasts were consumed on two occasions separated by a seven-day wash-
out period. The intervention breakfast consisted of 62.5 g honey-plain breakfast biscuits with 
chocolate chips and 180 mL skimmed milk. The control breakfast was composed of 56 g chocolate 
flavoured cereals and 180 mL full fat milk. Each breakfast also contained 10 g chocolate powder and 
80 mL orange juice. The breakfasts, which provided around 400 kcal of energy, were comparable with 
respect to macronutrient composition and dietary fibre content. The cereal products tested were 
comparable for total digestible starch (biscuits: 24.0 g, cereal: 21.3 g), total sugars (biscuits: 18.6 g, 
cereal: 23.9 g) and total fructose (biscuits: 8.4 g, cereal: 11.4 g). The biscuits contained 40.0 % of 
total digestible starch as “SDS” while this value for the control breakfast was 2.3 %. Blood glucose 
and insulin concentrations were measured at baseline, at 15 min, at 30 min and thereafter every 30 
min up to 240 min. All subjects completed the study. The iAUC for blood glucose concentrations (T0-
T120 min) was significantly lower after the consumption of the intervention breakfast than after the 
control breakfast (mean±SEM 50.6±10.8 vs. 89.3±16.9 mmol/L/min; p=0.03) as was the iAUC for 
insulin (T0-T120 min; mean±SEM 5123±291 vs. 6938±550 IU/L/min; p=0.004). The Panel notes that 
the consumption of 40 % of digestible starch as “SDS” induced significantly lower post-prandial 
glycaemic responses (without leading to disproportionally increased post-prandial insulinaemic 
responses) than the consumption of all digestible starch as “RDS” in cereal products containing about 
55 % of available carbohydrates as starch and 45 % as sugars.  
In a randomised, controlled parallel trial (Nazare et al., 2009) the effects of breakfast biscuits and 
wheat flakes consumed with breakfast on post-prandial blood glucose and insulin responses after an 
overnight fast were investigated in 38 overweight subjects (19 women, 23-57 years). The intervention 
breakfast consisted of 80 g biscuits and 180 mL semi-skimmed milk. The control breakfast was 
composed of 80 g breakfast cereals and 180 mL semi-skimmed milk. Subjects were allowed to 
consume a maximum of 300 mL of calorie-free hot beverage. The breakfasts, which provided around 
430 kcal of energy, were comparable with respect to macronutrient composition and dietary fibre 
content. The cereal products tested were comparable for total digestible starch (biscuits: 39.7 g, 
“Slowly digestible starch in starch-containing foods” and  
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cereal: 39.1 g), total sugars (biscuits: 18.9 g, cereal: 19.5 g) and total fructose (biscuits: 9.2 g, cereal: 
9.6 g). The biscuits contained 53.1 % of total digestible starch as “SDS” while this value for the 
control breakfast was 2.0 %. Blood glucose and insulin concentrations were measured at baseline, 
every 15 min up to 90 min and thereafter every 30 min up to 270 min. The iAUC for blood glucose 
concentrations (T0-T120 min) was significantly lower after the consumption of the intervention 
breakfast than after the control breakfast (mean±SEM 95.5±15.9 vs. 152.7±13.5 mmol/L/min; 
p=0.01). No significant differences were observed with respect to the iAUC for insulin 
(T0-T120 min). The Panel notes that the consumption of 50 % of digestible starch as “SDS” induced 
significantly lower post-prandial glycaemic responses (without leading to disproportionally increased 
post-prandial insulinaemic responses) than the consumption of all digestible starch as “RDS” in cereal 
products containing about 70 % of available carbohydrates as starch and 30 % as sugars.  
In an open-label, randomised, controlled cross-over study (Laville et al., 2005, unpublished) the effect 
of breakfast biscuits and wheat flakes consumed with breakfast and after an overnight fast on post-
prandial blood glucose and insulin responses were investigated in 12 healthy men (18-40 years). 
Breakfasts were consumed on two occasions separated by a two-week wash-out period and a 3-week 
run-in period in which the respective breakfasts were consumed. The intervention breakfast consisted 
of 70 g biscuits and 250 mL semi-skimmed milk. The control breakfast was composed of 70 g wheat 
flakes and 250 mL full fat milk. Subjects were allowed to consume a maximum of 300 mL of 
unsweetened tea or coffee. The breakfasts, which provided around 440 kcal of energy, were 
comparable with respect to macronutrient composition and dietary fibre content. The cereal products 
tested were comparable for total digestible starch (biscuits: 34.7 g, cereal: 39.4 g), total sugars 
(biscuits: 15.7 g, cereal: 17.5 g) and total fructose (biscuits: 7.4 g, cereal: 10.0 g). The biscuits 
contained 34.6 % of total digestible starch as “SDS” while this value for the control breakfast was 
2.3 %. Blood glucose and insulin concentrations were measured at baseline and every 30 min up to 
270 min. No significant differences were observed under the conditions of the study with respect to 
the iAUC for blood glucose or insulin concentrations (T0-T120 min). The Panel notes that the 
consumption of 30 % of digestible starch as “SDS” did not induce significantly lower post-prandial 
glycaemic responses (without leading to disproportionally increased post-prandial insulinaemic 
responses) than the consumption of all digestible starch as “RDS” in cereal products containing about 
70 % of available carbohydrates as starch and 30 % as sugars.  
The Panel notes that the studies provided consistently showed that consumption of 40-50 % of 
digestible starch as “SDS” in cereal products containing about 55-70 % of available carbohydrates as 
starch and 30-45 % as sugars in the context of a meal providing at least 60 E% of available 
carbohydrates induced significantly lower post-prandial glycaemic responses (without leading to 
disproportionally increased post-prandial insulinaemic responses) than the consumption of all 
digestible starch as “RDS” in cereal products with a similar content of available carbohydrates, starch 
and sugars. Cereal products, however, providing around 30 % of digestible starch as “SDS” and 
containing around 70 % of available carbohydrates as starch and 30 % as sugars did not show such an 
effect. The Panel also notes that a reduction in the sugar content in these cereal products is expected 
to have a similar effect on post-prandial glycaemic responses.  
The Panel concludes that a cause and effect relationship has been established between the 
consumption of “SDS”, as compared to the consumption of “RDS”, in cereal products and reduced 
post-prandial glycaemic responses (without disproportionally increased post-prandial insulinaemic 
responses). 
The Panel notes that other in vitro methods (in addition to the method developed by Englyst et al. 
(1996; 1999) following in vivo chewing to determine the rate of starch (and carbohydrate) 
digestibility in starchy foods have been developed, described, and modified by different authors 
(reviewed by Woolnough et al., 2008), and that many of these methods have been validated in vivo 
(e.g. Brighenti et al., 1995; Granfeldt et al., 1992; Seal et al., 2003) with respect to the post-prandial 
glycaemic and insulinaemic responses induced by such foods in different population sub-groups (e.g. 
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healthy subjects, subjects with type 2 diabetes on diet only and under hypoglycaemic medications, 
subjects with celiac disease) (e.g. Berti et al., 2004; Giacco et al., 2001; Holm and Bjorck, 1992; Seal 
et al., 2003). The Panel also notes that, although these methods encompass simulations of oral, gastric 
and intestinal digestion processes, the way in which physiological conditions are simulated differs 
considerably, and that these differences may have a substantial influence on the post-prandial 
glycaemic responses predicted for a particular food, and that there is currently no consensus on a 
single in vitro method for the measurement of the rate of starch (and carbohydrate) digestibility in 
starch-containing foods providing the highest predictive values with respect to the induced post-
prandial glycaemic (and insulinaemic) responses in vivo in humans (Woolnough et al., 2008). No 
inter-laboratory comparison is available at present for any of these methods.  
Therefore, the Panel could have reached the conclusion that the rate of starch digestibility assessed in 
vitro (e.g. by the method developed by Englyst et al. (1996; 1999)) in cereal products has an effect on 
post-prandial glycaemic responses in vivo in humans without the data marked as proprietary by the 
applicant. However, the four unpublished studies claimed as proprietary by the applicant were 
required to establish conditions of use for this specific claim.  
4. Panel’s comments on the proposed wording 
The Panel considers that the following wording reflects the scientific evidence: “Consumption of 
cereal products high in slowly digestible starch raises blood glucose concentrations less after a meal 
than cereal products low in slowly digestible starch”. 
5. Conditions and restrictions of use  
The Panel considers that, in order to bear the claim, cereal products should contain at least 55 % of 
available carbohydrates as starch of which at least 40 % should be “SDS”. The target population is 
individuals who wish to reduce their post-prandial blood glucose responses.  
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food constituent, “slowly digestible starch (SDS)”, as defined by the applicant in 
applying an appropriate method (such as the method developed by Englyst et al. (1996; 
1999)), which is the subject of the health claim, and the comparator food constituent, “rapidly 
digestible starch (RDS)”, as defined by the applicant, are sufficiently characterised in relation 
to the claimed effect.  
 The claimed effect proposed by the applicant relates to the reduction of post-prandial 
glycaemic responses. The target population proposed for the claim is the general population. 
Reduction of post-prandial glycaemic responses (as long as post-prandial insulinaemic 
responses are not disproportionally increased) may be a beneficial physiological effect.  
 A cause and effect relationship has been established between the consumption of “SDS”, as 
compared to the consumption of “RDS”, in cereal products and reduced post-prandial 
glycaemic responses (without disproportionally increased post-prandial insulinaemic 
responses). 
 The following wording reflects the scientific evidence: “Consumption of cereal products high 
in slowly digestible starch raises blood glucose concentrations less after a meal than cereal 
products low in slowly digestible starch”. 
“Slowly digestible starch in starch-containing foods” and  
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 In order to bear the claim, cereal products should contain at least 55 % of available 
carbohydrates as starch of which at least 40 % should be “SDS”. The target population is 
individuals who wish to reduce their post-prandial blood glucose responses.  
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on “slowly digestible starch in starch-containing foods” and “reduction of 
post-prandial glycaemic responses” pursuant to Article 13(5) of Regulation (EC) No 1924/2006 
(Claim serial No: 0284_BE). October 2010. Submitted by Kraft Foods Europe. 
REFERENCES 
Berti C, Riso P, Monti LD and Porrini M, 2004. In vitro starch digestibility and in vivo glucose 
response of gluten-free foods and their gluten counterparts. European Journal of Nutrition, 43, 
198-204. 
Brand-Miller JC, Holt S, Atkinson F, Fuzellier G and Agnetti V, 2006, unpublished. Determination of 
the postprandial responses to two cereal foods eaten alone or as part of a mixed meal. 
Brighenti F, Pellegrini N, Casiraghi MC and Testolin G, 1995. In vitro studies to predict physiological 
effects of dietary fibre. European Journal of Clinical Nutrition, 49 Suppl 3, S81-88. 
Englyst HN, Veenstra J and Hudson GJ, 1996. Measurement of rapidly available glucose (RAG) in 
plant foods: a potential in vitro predictor of the glycaemic response. British Journal of Nutrition, 
75, 327-337. 
Englyst KN, Englyst HN, Hudson GJ, Cole TJ and Cummings JH, 1999. Rapidly available glucose in 
foods: an in vitro measurement that reflects the glycemic response. American Journal of Clinical 
Nutrition, 69, 448-454. 
Giacco R, Brighenti F, Parillo M, Capuano M, Ciardullo AV, Rivieccio A, Rivellese AA and Riccardi 
G, 2001. Characteristics of some wheat-based foods of the Italian diet in relation to their influence 
on postprandial glucose metabolism in patients with type 2 diabetes. British Journal of Nutrition, 
85, 33-40. 
Granfeldt Y, Bjorck I, Drews A and Tovar J, 1992. An in vitro procedure based on chewing to predict 
metabolic response to starch in cereal and legume products. European Journal of Clinical 
Nutrition, 46, 649-660. 
Holm J and Bjorck I, 1992. Bioavailability of starch in various wheat-based bread products: 
evaluation of metabolic responses in healthy subjects and rate and extent of in vitro starch 
digestion. American Journal of Clinical Nutrition, 55, 420-429. 
Laville M, Rabasa-Lhoret R, Normand S and Braesco V, 2005, unpublished. Measurement of 
metabolic outcome of carbohydrates of two types pf cereal products. 
Nazare JA, de Rougemont A, Normand S, Sauvinet V, Sothier M, Vinoy S, Desage M and Laville M, 
2009. Effect of postprandial modulation of glucose availability: short- and long-term analysis. 
British Journal of Nutrition, 103, 1461-1470. 
Rabasa-Lhoret R, Peronnet F, Jannot C, Fuzellier G and Gausseres N, 2007, unpublished. Metabolic 
fate of four cereal products consumed as part of a breakfast by healthy female subjects. 
Seal CJ, Daly ME, Thomas LC, Bal W, Birkett AM, Jeffcoat R and Mathers JC, 2003. Postprandial 
carbohydrate metabolism in healthy subjects and those with type 2 diabetes fed starches with slow 
and rapid hydrolysis rates determined in vitro. British Journal of Nutrition, 90, 853-864. 
Venn BJ and Green TJ, 2007. Glycemic index and glycemic load: measurement issues and their effect 
on diet-disease relationships. European Journal of Clinical Nutrition, 61 Suppl 1, S122-131. 
“Slowly digestible starch in starch-containing foods” and  
“reduction of post-prandial glycaemic responses” 
 
 
14 EFSA Journal 2011;9(7):2292 
Vinoy S, Aubert R and Chapelot D, 2000, unpublished. A cereal product high in slowly availalble 
glucose increases subsequent satiety feelings and decreases glucose and insulin responses. 
Woolnough JW, Monro JA, Brennan CS and Bird AR, 2008. Simulating human carbohydrate 
digestion in vitro: a review of methods and the need for standardisation. International Journal of 
Food Science & Technology, 43, 2245-2256. 
 
 
“Slowly digestible starch in starch-containing foods” and  
“reduction of post-prandial glycaemic responses” 
 
 
15 EFSA Journal 2011;9(7):2292 
GLOSSARY AND ABBREVIATIONS 
FSG Free-sugar glucose 
iAUC Incremental area under the curve 
RDS Rapidly digestible starch 
SDS Slowly digestible starch 
